Day Zero Diagnostics Welcomes Healthcare Business Leader Gail Marcus to its Board
November 9 2022
Day Zero Diagnostics Inc. announced that Gail Marcus has joined the company’s Board of Directors as an independent director.
Read More
Day Zero Diagnostics Awarded $8.2 Million in Additional CARB-X Funding To Support Ongoing Development of its Infectious Disease Rapid Diagnostic
October 20 2022
DZD Will Continue Clinical Validation and Product Engineering of its Novel Technology Designed to Reduce Time to Diagnosis from Days to Hours
Read More
Day Zero Diagnostics Welcomes Molecular Diagnostics Experts to its Advisory Board
August 25 2022
Dr. Amy Mathers and Rob Crisp Bring Extensive Academic and Industry Experience
Read More
Day Zero Diagnostics Announces the Launch of Day Zero Lab Services
April 8 2022
Providing Whole Genome Sequencing Based Services for High Impact Clinical Decisions
Read More
Day Zero Diagnostics Announces Completion of $21M Financing
February 8 2022
Funding development of a disruptive whole-genome sequencing-based diagnostic system for bloodstream infections
Read More
Day Zero Diagnostics Wins the New Life Sciences Diagnostic Category at the Annual UCSF Health Awards
October 11 2021
Pioneering a New Class of Culture-free, Sequencing Diagnostics to Help Patients with Severe Infections
Read More